Logo
Nazad
Tobias Bittner, M. Tonietto, G. Klein, Anton Belusov, Vittorio Illiano, N. Voyle, Paul Delmar, M. A. Scelsi, Susanna Gobbi, Erica Silvestri, M. Barakovic, Antonio Napolitano, Christopher Galli, M. Abaei, K. Blennow, F. Barkhof
21 30. 1. 2025.

Biomarker treatment effects in two phase 3 trials of gantenerumab

We report biomarker treatment effects in the GRADUATE I and II phase 3 studies of gantenerumab in early Alzheimer's disease (AD).


Pretplatite se na novosti o BH Akademskom Imeniku

Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo

Saznaj više